NCT07511023: Phase 2 Trial Of Sacituzumab Tirumotecan For Treatment Of Refractory Metastatic Or Unresectable Squamous Cell Carcinoma Of The Anus/Rectum
- State
- Not started
- Phase
- Phase 2
- People
- 20 planned
- Started
- 25 Sep 2026
- Primary completion
- 1 Mar 2031
- Arms
- Phase 2: Treatment with Sacituzumab Tirumotecan
- Results
- None posted
- 6 Apr 2026: Trial registered